KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Operating Income (2016 - 2025)

Historic Operating Income for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to -$38.9 million.

  • Pacific Biosciences Of California's Operating Income rose 3932.77% to -$38.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$665.7 million, marking a year-over-year decrease of 6282.74%. This contributed to the annual value of -$474.3 million for FY2024, which is 4181.16% down from last year.
  • Latest data reveals that Pacific Biosciences Of California reported Operating Income of -$38.9 million as of Q3 2025, which was up 3932.77% from -$44.9 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Operating Income ranged from a high of -$33.7 million in Q1 2021 and a low of -$428.9 million during Q1 2025
  • Over the past 5 years, Pacific Biosciences Of California's median Operating Income value was -$74.6 million (recorded in 2022), while the average stood at -$96.8 million.
  • Within the past 5 years, the most significant YoY rise in Pacific Biosciences Of California's Operating Income was 7449.3% (2025), while the steepest drop was 42719.21% (2025).
  • Pacific Biosciences Of California's Operating Income (Quarter) stood at -$64.7 million in 2021, then tumbled by 34.65% to -$87.1 million in 2022, then dropped by 0.53% to -$87.5 million in 2023, then tumbled by 74.79% to -$153.0 million in 2024, then surged by 74.59% to -$38.9 million in 2025.
  • Its last three reported values are -$38.9 million in Q3 2025, -$44.9 million for Q2 2025, and -$428.9 million during Q1 2025.